2H-1-Benzopyran-3-carboxylic acid, 7-methoxy-2-oxo-, 3-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]phenyl ester manufacturers
- HDAC-IN-42
-
- $3520.00
-
2026-04-20
- CAS:2454024-18-9
- Purity:
- Supply Ability: 10g
|
| | 2H-1-Benzopyran-3-carboxylic acid, 7-methoxy-2-oxo-, 3-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]phenyl ester Basic information |
| | 2H-1-Benzopyran-3-carboxylic acid, 7-methoxy-2-oxo-, 3-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]phenyl ester Chemical Properties |
| density | 1.430±0.06 g/cm3(Predicted) | | pka | 8+-.0.23(Predicted) |
| | 2H-1-Benzopyran-3-carboxylic acid, 7-methoxy-2-oxo-, 3-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]phenyl ester Usage And Synthesis |
| Uses | HDAC-IN-42 (compound 14f) is a potent and selective HDAC inhibitor with IC50 values of 0.19 and 4.98 μM for HDAC1 and HDAC6, respectively. HDAC-IN-42 shows anticancer and anti-proliferative activity. HDAC-IN-42 induces apoptosis and cell cycle arrest at G2/M phase[1]. | | IC 50 | HDAC1: 0.19 μM (IC50); HDAC6: 4.98 μM (IC50) | | References | [1] Ding J, et al. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities. Bioorg Chem. 2020 Aug;101:104023. DOI:10.1016/j.bioorg.2020.104023 |
| | 2H-1-Benzopyran-3-carboxylic acid, 7-methoxy-2-oxo-, 3-[(1E)-3-(hydroxyamino)-3-oxo-1-propen-1-yl]phenyl ester Preparation Products And Raw materials |
|